News Daily News Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI Yael L. Maxwell December 29, 2025
News Daily News PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone Michael O'Riordan November 24, 2023
News Conference News EuroPCR 2023 Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization Michael O'Riordan May 19, 2023
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Conference News ACC 2021 FFR Doesn’t Beat Angio for Complete Revasc in STEMI: FLOWER-MI Caitlin E. Cox May 25, 2021
News Conference News TCT 2020 Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB Michael O'Riordan October 14, 2020
News Daily News PCI Volumes Rise in US and Japan, but for Different Reasons Michael O'Riordan September 14, 2020
News Daily News FFR Deferral of Nonculprit Lesions Riskier in ACS vs Stable Angina Caitlin E. Cox August 03, 2020
News Daily News FFR for Stable Patients With Intermediate CAD? VA Analysis Stokes Debate Michael O'Riordan January 27, 2020
News Opinion Editor's Corner ISCHEMIA Questions? Some Answers From David Maron Shelley Wood December 09, 2019
News Daily News For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality Michael O'Riordan December 05, 2019
News Daily News Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit Shelley Wood October 14, 2019
News Conference News ACC 2019 High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI Michael O'Riordan March 21, 2019
News Daily News FARGO: FFR No Help for CABG in Patients With Multivessel Disease L.A. McKeown November 27, 2018
News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Conference News ESC 2018 FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice Todd Neale August 26, 2018
News Daily News ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights Michael O'Riordan July 10, 2018
News Features Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate Michael O'Riordan November 27, 2017
News Conference News ACC 2017 iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions Caitlin E. Cox March 18, 2017
News Conference News AHA 2016 Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study Michael O'Riordan November 14, 2016